College of Medicine

Yang Hou, Ph.D., Principal Investigator of the Development, Equity, and Resilience (DEaR) Lab, was honored to take part in the “Cognition and Behavior in Neurofibromatosis type 1 (NF1)” conference in New York. There she shared insights on neurobehavioral function of individuals with NF1, a genetic disorder that often develops various tumors and exhibits more neurobehavioral problems (e.g., cognitive deficits and learning difficulties) than the general population. The DEaR Lab is looking forward to launching their collaborative projects, advancing the NF field, and promoting resilience in individuals with NF1!